Terug
Dagbereik
€ 16,70
€ 17,77
52-Weeksbereik
€ 3,42
€ 30,00
Volume
723.762
50D / 200D Gem.
€ 20,20
/
€ 19,19
Vorige Slotkoers
€ 17,30
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -5,6 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -139,8 | 3,8 |
| Rev Growth 5Y % | 23,0 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 35,60
+101.6%
Low: € 16,00
High: € 60,00
Forward WPA
-€ 1,17
Omzet Sch.
240 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,62
€ 5,56 – € 8,21
|
1 B | 1 |
| FY2029 |
€ 4,96
€ 4,16 – € 6,15
|
780 M | 1 |
| FY2028 |
€ 2,17
€ 0,02 – € 3,03
|
550 M | 5 |
Belangrijkste Punten
Revenue grew 22,95% annually over 5 years — strong growth
Negative free cash flow of -162,73M
Capital efficient — spends only 0,26% of revenue on capex
Groei
Revenue Growth (5Y)
22,95%
Revenue (1Y)21,45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-409,69%
Net Margin-139,81%
Op. Margin-113,73%
Veiligheid
Debt / Equity
N/A
Current Ratio4,01
Interest Coverage-3,69
Waardering
P/E Ratio
-5,60
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21,45% | Revenue Growth (3Y) | 15,21% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 22,95% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 109,79M | Net Income (TTM) | -153,49M |
| ROE | N/A | ROA | -76,57% |
| Gross Margin | 88,66% | Operating Margin | -113,73% |
| Net Margin | -139,81% | Free Cash Flow (TTM) | -162,73M |
| ROIC | -409,69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,01 |
| Interest Coverage | -3,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -5,60 | P/B Ratio | N/A |
| P/S Ratio | 7,83 | PEG Ratio | -0,94 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 859,73M | Enterprise Value | 877,32M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 109,79M | 90,40M | 82,71M | 64,36M | 48,04M |
| Net Income | -153,49M | -126,87M | -102,24M | -109,78M | -110,82M |
| EPS (Diluted) | -3,19 | -2,96 | -3,55 | -4,79 | -4,96 |
| Gross Profit | 97,34M | 81,52M | 73,35M | 56,70M | 42,89M |
| Operating Income | -124,86M | -96,78M | -65,54M | -79,04M | -92,29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 200,46M | 285,71M | 178,31M | 135,62M | 119,75M |
| Total Liabilities | 305,93M | 294,51M | 243,52M | 224,98M | 111,33M |
| Shareholders' Equity | -105,47M | -8,80M | -65,21M | -89,36M | 8,41M |
| Total Debt | 128,33M | 123,39M | 99,40M | 99,12M | 398.000,0 |
| Cash & Equivalents | 110,75M | 171,99M | 95,00M | 55,41M | 44,36M |
| Current Assets | 186,02M | 276,14M | 169,19M | 128,91M | 114,39M |
| Current Liabilities | 46,42M | 45,95M | 31,21M | 23,92M | 22,38M |